Health In Tech, Inc. Reports Director/Officer Changes

TL;DR

Health In Tech (HIT) filed an 8-K detailing director and officer changes effective 8/15.

AI Summary

Health In Tech, Inc. filed an 8-K on August 19, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing covers events as of August 15, 2025. The company is incorporated in Nevada and its principal executive offices are located in Stuart, Florida.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing is routine corporate governance disclosure and does not contain immediate financial or operational risks.

Key Players & Entities

• Health In Tech, Inc. (company) — Registrant
• August 15, 2025 (date) — Date of earliest event reported
• August 19, 2025 (date) — Date of report
• Nevada (jurisdiction) — State of incorporation
• Stuart, FL (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — hich registered Class A Common Stock, $0.001 par value per share HIT The Nasdaq

Filing Documents

• ea0253563-8k_health.htm (8-K) — 28KB
• 0001213900-25-078148.txt ( ) — 192KB
• hit-20250815.xsd (EX-101.SCH) — 3KB
• hit-20250815_lab.xml (EX-101.LAB) — 33KB
• hit-20250815_pre.xml (EX-101.PRE) — 22KB
• ea0253563-8k_health_htm.xml (XML) — 4KB

02 Departure of Directors or Certain

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 15, 2025, the Compensation Committee of the Board of Directors of Health In Tech, Inc., a Nevada corporation (the "Company"), approved the grant of restricted stock awards (the "RSAs") to Tim Johnson, the Company's Chief Executive Officer, Linlin (Julia) Qian, the Company's Chief Financial Officer, and (Mo) Imran Yousuf, the Company's Chief Technology Officer. The Company granted the RSAs to Mr. Johnson, Ms. Qian and Mr. Yousef in connection with services these named executive officers are providing to the Company to develop two new programs, which are referred to in this Current Report on Form 8-K as "Program 1" and "Program 2", and collectively as, the "Programs". Mr. Johnson received a grant of 17,000 shares of restricted stock in connection with Program 1 and 17,000 shares of restricted stock in connection with Program 2. Ms. Qian received a grant of 10,000 shares of restricted stock in connection with Program 1 and 17,000 shares of restricted stock in connection with Program 2. Mr. Yousuf received a grant of 3,500 shares of restricted stock in connection with Program 1 and 3,500 shares of restricted stock in connection with Program 2. Fifty percent (50%) of the total number of shares of restricted stock granted to each recipient shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the first of the two Programs is successfully launched and fully operational in the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing on the date that the other Program is successfully launched and fully operational in the marketplace. The RSAs were granted pursuant to the Health In Tech, Inc. Equity Incentive Plan and are subject to the terms and conditions set forth in the Restricted St

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 19, 2025 HEALTH IN TECH, INC. By: /s/ Tim Johnson Name: Tim Johnson Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR